This is so cool_老虎社区_美港股上老虎

SDQwerty
2021-03-17

This is so cool

16 small-cap stocks that could get a boost from ETF buying

The Russell family of indexes will add several newly-public companies in March, at which point excha

16 small-cap stocks that could get a boost from ETF buying

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":324230653,"tweetId":"324230653","gmtCreate":1615993415772,"gmtModify":1703496142361,"author":{"id":3561701296039483,"idStr":"3561701296039483","authorId":3561701296039483,"authorIdStr":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>This is so cool</p></body></html>","htmlText":"<html><head></head><body><p>This is so cool</p></body></html>","text":"This is so cool","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/324230653","repostId":2120187580,"repostType":4,"repost":{"id":"2120187580","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615991880,"share":"https://www.laohu8.com/m/news/2120187580?lang=&edition=full","pubTime":"2021-03-17 22:38","market":"us","language":"en","title":"16 small-cap stocks that could get a boost from ETF buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2120187580","media":"Dow Jones","summary":"The Russell family of indexes will add several newly-public companies in March, at which point excha","content":"<p>The Russell family of indexes will add several newly-public companies in March, at which point exchange-traded funds that track the indexes will need to buy shares in those companies. That buying activity could provide a boost to share prices, according to an analysis from Jefferies.</p>\n<p>\"A number of names could see decent tailwind,\" the Jefferies analysts wrote. Those 16 stocks are in the table below, along with the number of days over which Jefferies calculates they will see buying pressure.</p>\n<p>There are some caveats.</p>\n<p>\"We are adding to the growing list of concerns regarding small-cap performance moving too far, too fast,\" the analysts explain.</p>\n<p>As of Friday's open, the Russell 2000 is up 8.7% in the year to date, compared to a flat showing for the S&amp;P 500 and a negative <a href=\"https://laohu8.com/S/AONE\">one</a> for the Nasdaq .</p>\n<p>What's more, companies have been rushing to go public at a pace not seen since 1997 -- eclipsing even the 1999-2000 dot-com bubble.</p>\n<p>\"When the IPO calendar has been this hot in the past, performance has cooled,\" Jefferies wrote. \"We don't see negative performance but Small does tend to lag over the subsequent 6 and 12 months as investors digest the new names.\"</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company and ticker</td>\n   <td>Days to buy</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MDWT\">Midwest Holding Inc.</a>MDWT</td>\n   <td>15.2</td>\n  </tr>\n  <tr>\n   <td>Olema Pharmaceuticals Inc. OLMA</td>\n   <td>14.2</td>\n  </tr>\n  <tr>\n   <td>Silverback TherapeuticsInc.SBTX</td>\n   <td>11.1</td>\n  </tr>\n  <tr>\n   <td>Kinnate Biopharma Inc.KNTE</td>\n   <td>11</td>\n  </tr>\n  <tr>\n   <td>Sigilon TherapeuticsSGTX</td>\n   <td>9.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FDMT\">4D Molecular Therapeutics</a> IncFDMT</td>\n   <td>9.3</td>\n  </tr>\n  <tr>\n   <td>Ortho Clinical Diagnostics HoldingsOCDX</td>\n   <td>9</td>\n  </tr>\n  <tr>\n   <td>Terns Pharmaceuticals Inc.TERN</td>\n   <td>8.5</td>\n  </tr>\n  <tr>\n   <td>Cullinan OncologyCGEM</td>\n   <td>7.5</td>\n  </tr>\n  <tr>\n   <td>Bolt Biotherapeutics Inc.BOLT</td>\n   <td>7.2</td>\n  </tr>\n  <tr>\n   <td>Vor BiopharmaVOR</td>\n   <td>6.8</td>\n  </tr>\n  <tr>\n   <td>NeximmuneNEXI</td>\n   <td>6.5</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MASS\">908 Devices Inc.</a>MASS</td>\n   <td>5.8</td>\n  </tr>\n  <tr>\n   <td>BioAtlaInc.BCAB</td>\n   <td>5.5</td>\n  </tr>\n  <tr>\n   <td>Talis BiomedicalTLIS</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Decibel Therapeutics Inc.DBTX</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Source: Jefferies</td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Jefferies explains that they calculated \"days to buy\" like so: \"We took the weight of each name across the Russell indexes, multiplied that by our best guess as to how many passive assets are pegged to each index to come up with dollars to buy. We then divide the dollars by its price to come up with shares to buy. We then took the average last 10-days of trading volume to determine the days to buy.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>16 small-cap stocks that could get a boost from ETF buying</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n16 small-cap stocks that could get a boost from ETF buying\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-17 22:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The Russell family of indexes will add several newly-public companies in March, at which point exchange-traded funds that track the indexes will need to buy shares in those companies. That buying activity could provide a boost to share prices, according to an analysis from Jefferies.</p>\n<p>\"A number of names could see decent tailwind,\" the Jefferies analysts wrote. Those 16 stocks are in the table below, along with the number of days over which Jefferies calculates they will see buying pressure.</p>\n<p>There are some caveats.</p>\n<p>\"We are adding to the growing list of concerns regarding small-cap performance moving too far, too fast,\" the analysts explain.</p>\n<p>As of Friday's open, the Russell 2000 is up 8.7% in the year to date, compared to a flat showing for the S&amp;P 500 and a negative <a href=\"https://laohu8.com/S/AONE\">one</a> for the Nasdaq .</p>\n<p>What's more, companies have been rushing to go public at a pace not seen since 1997 -- eclipsing even the 1999-2000 dot-com bubble.</p>\n<p>\"When the IPO calendar has been this hot in the past, performance has cooled,\" Jefferies wrote. \"We don't see negative performance but Small does tend to lag over the subsequent 6 and 12 months as investors digest the new names.\"</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company and ticker</td>\n   <td>Days to buy</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MDWT\">Midwest Holding Inc.</a>MDWT</td>\n   <td>15.2</td>\n  </tr>\n  <tr>\n   <td>Olema Pharmaceuticals Inc. OLMA</td>\n   <td>14.2</td>\n  </tr>\n  <tr>\n   <td>Silverback TherapeuticsInc.SBTX</td>\n   <td>11.1</td>\n  </tr>\n  <tr>\n   <td>Kinnate Biopharma Inc.KNTE</td>\n   <td>11</td>\n  </tr>\n  <tr>\n   <td>Sigilon TherapeuticsSGTX</td>\n   <td>9.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FDMT\">4D Molecular Therapeutics</a> IncFDMT</td>\n   <td>9.3</td>\n  </tr>\n  <tr>\n   <td>Ortho Clinical Diagnostics HoldingsOCDX</td>\n   <td>9</td>\n  </tr>\n  <tr>\n   <td>Terns Pharmaceuticals Inc.TERN</td>\n   <td>8.5</td>\n  </tr>\n  <tr>\n   <td>Cullinan OncologyCGEM</td>\n   <td>7.5</td>\n  </tr>\n  <tr>\n   <td>Bolt Biotherapeutics Inc.BOLT</td>\n   <td>7.2</td>\n  </tr>\n  <tr>\n   <td>Vor BiopharmaVOR</td>\n   <td>6.8</td>\n  </tr>\n  <tr>\n   <td>NeximmuneNEXI</td>\n   <td>6.5</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MASS\">908 Devices Inc.</a>MASS</td>\n   <td>5.8</td>\n  </tr>\n  <tr>\n   <td>BioAtlaInc.BCAB</td>\n   <td>5.5</td>\n  </tr>\n  <tr>\n   <td>Talis BiomedicalTLIS</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Decibel Therapeutics Inc.DBTX</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Source: Jefferies</td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Jefferies explains that they calculated \"days to buy\" like so: \"We took the weight of each name across the Russell indexes, multiplied that by our best guess as to how many passive assets are pegged to each index to come up with dollars to buy. We then divide the dollars by its price to come up with shares to buy. We then took the average last 10-days of trading volume to determine the days to buy.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2120187580","content_text":"The Russell family of indexes will add several newly-public companies in March, at which point exchange-traded funds that track the indexes will need to buy shares in those companies. That buying activity could provide a boost to share prices, according to an analysis from Jefferies.\n\"A number of names could see decent tailwind,\" the Jefferies analysts wrote. Those 16 stocks are in the table below, along with the number of days over which Jefferies calculates they will see buying pressure.\nThere are some caveats.\n\"We are adding to the growing list of concerns regarding small-cap performance moving too far, too fast,\" the analysts explain.\nAs of Friday's open, the Russell 2000 is up 8.7% in the year to date, compared to a flat showing for the S&P 500 and a negative one for the Nasdaq .\nWhat's more, companies have been rushing to go public at a pace not seen since 1997 -- eclipsing even the 1999-2000 dot-com bubble.\n\"When the IPO calendar has been this hot in the past, performance has cooled,\" Jefferies wrote. \"We don't see negative performance but Small does tend to lag over the subsequent 6 and 12 months as investors digest the new names.\"\n\n\n\nCompany and ticker\nDays to buy\n\n\nMidwest Holding Inc.MDWT\n15.2\n\n\nOlema Pharmaceuticals Inc. OLMA\n14.2\n\n\nSilverback TherapeuticsInc.SBTX\n11.1\n\n\nKinnate Biopharma Inc.KNTE\n11\n\n\nSigilon TherapeuticsSGTX\n9.9\n\n\n4D Molecular Therapeutics IncFDMT\n9.3\n\n\nOrtho Clinical Diagnostics HoldingsOCDX\n9\n\n\nTerns Pharmaceuticals Inc.TERN\n8.5\n\n\nCullinan OncologyCGEM\n7.5\n\n\nBolt Biotherapeutics Inc.BOLT\n7.2\n\n\nVor BiopharmaVOR\n6.8\n\n\nNeximmuneNEXI\n6.5\n\n\n908 Devices Inc.MASS\n5.8\n\n\nBioAtlaInc.BCAB\n5.5\n\n\nTalis BiomedicalTLIS\n5.0\n\n\nDecibel Therapeutics Inc.DBTX\n5.0\n\n\nSource: Jefferies\n\n\n\n\nJefferies explains that they calculated \"days to buy\" like so: \"We took the weight of each name across the Russell indexes, multiplied that by our best guess as to how many passive assets are pegged to each index to come up with dollars to buy. We then divide the dollars by its price to come up with shares to buy. We then took the average last 10-days of trading volume to determine the days to buy.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":391,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}